Girifl ve Amaç: Helikobakter pilori enfeksiyonunun de¤erlendirilmesinde invaziv olmayan testlere ilgi artm›fl ve idrar temelli testler Helikobakter pilori enfeksiyonunu saptamada invaziv olmayan testler olarak s›k kullan›lmaktad›r. Bu çal›flmada Türk eriflkin dispeptik hastalarda idrarda sal›nan anti-Helikobakter pilori IgG antikorunu saptamada hasta bafl› idrar kart testi ve idrar antikor enzim-ba¤l›
INTRODUCTION
Helicobacter pylori (H. pylori) is etiologically associated with gastritis, gastric and duodenal ulcers, gastric adenocarcinoma, and mucosa-associated lymphoid tissue (MALT) lymphoma (1) (2) (3) (4) (5) (6) . H. pylori infection is very common worldwide, occurring in 40-50% of the population in developed countries and 80-90% of the population in developing regions (7, 8) . Urea breath test (UBT) and culture are gold standard methods for detecting H. pylori infection (1) (2) (3) (4) 6, (9) (10) (11) . Easy and noninvasive methods for screening H. pylori infection were determined necessary (11) . In addition to the invasive tests, stool antigen test, urine antibodies test and serum antibody test are available as noninvasive tests in the diagnosis of H. pylori infection (1) (2) (3) (4) 6, (9) (10) (11) . A single test is not sufficient to diagnose H. pylori infection without culture. The European guidelines indicate that the gold standard is positivity of at least two different tests. Endoscopy was generally used in the diagnosis of H. pylori, but it is an expensive and invasive method. The test and treat strategy recommends a noninvasive test in patients without alarm symptoms who are <55 years old and not using nonsteroidal anti-inflammatory drugs (NSAIDs). Endoscopy is recommended for patients with alarm symptoms who are >55 years old (4) . Noninvasive tests have become part of the management strategies for patients with dyspepsia (12) , and they can be active or passive. Active tests detect the presence of H. pylori and provide evidence of a current infection. Passive tests that detect antibodies provide evidence of exposure to H. pylori but do not necessarily indicate an active infection (4) . Serological tests are based on the detection of a specific anti-H. pylori immunological response, mostly by IgG antibodies, in the patient's serum (13) . Recently, new methods for the detection of anti-H. pylori IgG antibody in urine were developed, and their clinical usefulness has been noted in adult populations (6, 13 ).
An enzyme immunoassay method (URINELISA, Otsuka Pharmaceutical, Tokyo, Japan) as well as a serum antibody testing and immunochromatographic method (RAPIRUN, Otsuka Pharmacautical, Tokyo, Japan) have been used for the detection of H. pylori infection (7). Noninvasive screening for IgG antibodies in urine has many potential advantages over blood-based antibody tests in terms of convenience and use in children (12) . The advantages of urine antibody tests are that urine can be collected easily and centrifugation is not required, and they combine the simplicity, cost-effectiveness and applicability under circumstances in which serological testing is impractical (7) .
Because of the widespread prevalence of H. pylori infection, simple, convenient, and noninvasive techniques are required as a screening tool for H. pylori infection. URINELISA and RAPIRUN have been proven to have sufficient accuracy so as to be used clinically (14, 15) . Urine-based enzyme-linked immunosorbent assay (ELISA) for the detection of IgG antibody to H. pylori has already been shown to have high sensitivity and specificity in adults (2).
We evaluated the efficacy and diagnostic value of URINELISA and RAPIRUN for the screening of H. pylori infection as well as how the diagnostic accuracy of a new cut-off value would influence the determination of H. pylori infection in adult patients with dyspepsia admitted to our hospital.
MATERIALS AND METHODS

Patients
One hundred twenty-four patients with dyspepsia (31 males, 93 females; mean age: 46 ± 12 years) who admitted to the Gastroenterology Clinic at Dokuz Eylül University Hospital and were referred for upper endoscopy were included in this study. Urine specimens and sera were collected on the same day as endoscopy. Patients were excluded if they had received proton pump inhibitors (PPIs) or antibiotic in the previous one month, had prior gastric surgery, were pregnant or lactating, had gastrointestinal malignancy, alcohol abuse, drug addiction, or chronic use of corticosteroids or NSAIDs. Six biopsy samples were taken from all patients (3 from the antrum, 3 from the corpus). Each antrum and corpus biopsy specimen was used for rapid urease test (RUT), histopathology and culture. After endoscopy, urine specimens and sera were collected on the same day. All patients gave their written informed consent in this study. H. pylori infection was defined as positivity of at least two of RUT, histopathology and culture results as gold standard methods. A patient was classified as H. pylori infection-negative when RUT, histopathological examination and culture were all negative or only one (histopathology or RUT result) was positive.
Rapid Urease Test and Histopathology
Three antrum and three corpus biopsy specimens were taken at endoscopy: One antrum and one corpus specimens were used for the RUT and the other two were immediately fixed and transported in 10% buffered formalin solution for histopathologic examination. Hematoxylin-eosin, Alcian blue and Giemsa stains were used for morphologic examination of Helicobacter-like organisms (HLO) according to the Updated Sydney System (16).
Culture
Each patient's antrum and corpus gastric biopsy specimens were collected into transport media (Brucella broth with 20% glycerol). These were homogenized separately and cultured separately on Columbia Blood Agar (Oxoid) plates containing 7% defibrinated horse blood (Oxoid) and supplemented with H. pylori selective supplement (DENT) (Oxoid). The inoculated plates were incubated at 37°C in anaerobic jar (Oxoid) under microaerophilic conditions (Gaspak Campy Container System; Beckton Dickinson) for 3-7 days. Cultured H. pylori strains were identified based on colony morphology, by microscopic examination for motility and morphology, and by Gram staining and positive reaction with oxidase, catalase and urease tests.
Serum Antibody Tests
Sera were collected on the same day as when biopsies were taken from patients undergoing endoscopy. Serum samples were aliquotted and stored at -20°C until used. Anti-H. pylori IgG ELISA (EUROIMMUN Medizinische Labordiagnostika, Lübeck, Germany) was used to detect the presence of H. pylori-specific serum antibodies according to the manufacturer's instructions. The recommended cut-off values were used.
Urine Antibody Tests
Urine samples were collected on the day of endoscopy. Urine samples were stored at 4°C before analysis. RAPIRUN H. pylori Antibody Test (Otsuka Pharmaceutical, Tokyo, Japan) is an immunochromatographic test for the detection of anti-H. pylori IgG antibody in urine. The urine sample (0.5 ml) was transferred into a sample diluent tube containing the sample diluent and mixed by pipetting using the same syringe; then, 0.2 to 0.3 ml of the mixture was added to the sampling part of the test device, and results were determined. The samples were considered positive when two red bands at the test line and control line were observed within 20 minutes (min), and samples were considered negative when only the control line was observed in 20 min (1, 5, 12, 13, (17) (18) (19) (20) . URINELISA H. pylori antibody test (Otsuka Pharmacautical, Tokyo, Japan) is an ELISA for the detection of anti-H. pylori IgG antibody in urine. A solid phase of an antigen, a protein extracted from an H. pylori strain isolated from a Japanese patient with gastritis, was used. The assay procedure was performed according to the manufacturer's recommendations. Absorbance was determined at a wavelength of 450 nm by an ELISA reader (Organon Technica Microwell System). Two positive controls and three negative controls were measured simultaneously. In the cut-off value index used, <1.0 was negative and ≥1.0 was positive according to manufacturer's instructions (2, 6, 7, 9, (12) (13) (14) . Meanwhile, we also searched for a new cut-off value to determine the best cut-off value result in concordance with the results of gold standard methods by receiver operating characteristic (ROC) analysis.
Consequently, the results of URINELISA were independently evaluated for kit cut-off value according to the manufacturer's instructions and our determined new cut-off value. All urine tests were performed without knowledge of the other test results.
Statistical Analysis
The McNemar χ 2 test was used. The sensitivity, specificity, positive predictive values (PPV), negative predictive values (NPV), and diagnostic accuracy were calculated (version 15.0; Statistical Package for the Social Sciences [SPSS]). A calculation of the ROC curve analysis was used to determine the best cut-off value for URINELISA.
Ethics
The research protocol was approved before the study began by the Institutional Review Board and the Ethical Committee of Dokuz Eylül University, Faculty of Medicine (03.02.2006/01). Figure 1) .
RESULTS
H. pylori infection was positive in
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When using the cut-off value of 1.000 (OD 1) as recommended by the manufacturer, the sensitivity, specificity, PPV, and NPV of the URINELISA test were 74.4%, 81.0%, 88.4%, and 61.8%, respectively. Although the sensitivity and specificity of URINELISA were acceptable, we wondered, when ROC curves were performed, whether or not it would influence the results correlated with gold standard methods. Thus, ROC curves were performed for URINELISA to reach the best new cut-off value in concordance with the results of gold standard methods in our patient groups. ROC curve allowed for the determination of the threshold, giving the best combination of sensitivity and specificity for URINELISA, indicating that the optimal cut-off value as indicated in the ROC curves was 0.530 (area under curve =0.866) for our patient population (Figure 2 ). When we used this optimal cut-off value of 0.530, the sensitivity, specificity, PPV, and NPV of URINELISA were 90.2%, 71.4%, 86.1%, and 79.0%, respectively (κ=0.631) (Table 2, Figure 1 ).
DISCUSSION
To our knowledge, our study is the first to determine the validity of URINELISA, which is a urinebased enzyme immunoassay, as a noninvasive test, among Turkish adult patients with dyspepsia in our university hospital. The advantages of urine-based enzyme immunoassays are that they are noninvasive, the sample collection is very simple (3,6,7) , it does not require centrifugation, and the cost of using urine as a sample is much lower than that of serum (4, 7, 20) . Antibody concentration in urine samples was approximately 1/10000 of antibody concentration in serum (12, 21) . Although anti-H. pylori IgG is at a low concentration in urine samples, it has been found to correlate with anti-H. pylori IgG in serum samples (5, 20) . In addition, antibodies to H. pylori in urine are stable for 60 days at 4°C (3, 6, 26) and for 3 days at 37°C (3,26) thus making routine transportation of urine samples to laboratories convenient (7) . The antibody activity of URINELI-SA in random single-void urine in humans was comparatively constant during a day and on different days, except for first-void morning urine (3). Although it can be used with randomly collected urine samples, too much water intake before urination should be avoided, as it can produce urine with a very low concentration of IgG (3, 11, 20) . Additionally, the patient's renal function, urine constituents and urine pH may influence the detection of urine antibodies (20) . We collected urine specimens before or after endoscopy on the same day. The patients did not eat or drink anything for 8 hours before endoscopy.
Muhsen et al. (22) reported the sensitivity and specificity of URINELISA in children as 34.2% and 96.3%, respectively. However, they evaluated only the stool antigen test as the gold standard method, so these results were limited. They found a new cut-off value of 0.066 for URINELISA for healthy Israeli children. Megraud et al. (9) found a new cut-off value of 0.2 for URINELISA. The H. pylori antigens used for the urine-based ELISA were extracted from a Japanese strain (2,3) . The different genetic background of patients and H. pylori strains could induce different antigen-antibody responses (7) . There is no study in the literature about urine antibody tests for Turkish adult dyspeptic patients. The sensitivity of URINELISA (25, 26) . The performance of an antibody detection-based kit is affected by the ethnic factor, and therefore, it is different in various patient populations (26) . URINELISA assay plates and RAPIRUN membranes contain antigens from H. pylori strain (OHPC-040), which have important genes (vacA, ureB and cagA) from Japanese patients (3, 9, 11, 18, 21, 22) . However, the urine antibody test accuracy did not differ between Asian and Western ethnic groups (26).
Opekun et al. (25) found that sensitivities of RA-PIRUN and serum IgG serology test (HM-CAP) were 90% and 85%, respectively. They concluded that RAPIRUN urine antibody test provided reliable information rapidly at the point of primary care. Nguyen et al. (5) found that the sensitivity and specificity of RAPIRUN test in 148 Vietnamese patients were 79.5% and 90.7%, respectively.
In conclusion, we found that URINELISA and RA-PIRUN were highly accurate, just as accurate as the serological tests, and also that they could be used as an alternative to the serological tests for detecting H. pylori infection in patients with dyspepsia. Both urine-based tests, URINELISA and RAPIRUN, were found highly specific for the diagnosis of H. pylori infection, and they were al- so more convenient and easy to use as a noninvasive method in clinical trials, especially at the point of primary care. Both tests would be useful for screening patients with dyspepsia. The best cutoff value of 0.530 for URINELISA was found to be more effective for the evaluation of patients with dyspepsia in our patient group. The isolates of H. pylori from different geographic regions can show antigenic variations, and URINELISA validated in one region may have variable results in other regions. Therefore, the optimal density value for URINELISA should be calculated and adjusted for the study population in each country.
